Neumora Therapeutics NMRA
NASDAQ NMRA
$0.44 -0.02 (-4.96%)
As of: Oct 21, 2026 · 10:37 AM EDT

Neumora Therapeutics (NMRA) Total Debt (2025 - 2026)

Updated

Neumora Therapeutics' Total Debt came in at $52.91 million for Q2 2026, up 172.0% from $19.45 million a year earlier but down 0.1% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Total Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Neumora Therapeutics' Total Debt was $54.53 million.

  • The five-year range for quarterly Total Debt is $19.45 million (Q2 2025) to $54.53 million (Q4 2025).
  • Business Quant data shows NMRA's Total Debt at $52.96 million (Q1 2026), $54.53 million (Q4 2025) and $19.56 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 49.04 Bn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn 70.82 Bn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn 63.19 Bn
10 Neumora Therapeutics 81.84 Mn -536.12 Mn - 52.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.91 Mn
Mar 31, 2026 52.96 Mn
Dec 31, 2025 54.53 Mn
Sep 30, 2025 19.56 Mn
Jun 30, 2025 19.45 Mn
API Access

Neumora Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NMRA&period=max&api_key=YOUR_API_KEY